Elisabetta Marangoni

28PUBLICATIONS
231CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cellular interactions (incl. adhesion, matrix, cell wall)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 08, 2026
PLK1 inhibition by onvansertib enhances paclitaxel efficacy and overcomes resistance in HR+/HER2- breast cancer refractory to endocrine therapy and CDK4/6 inhibitors.

|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

|Nov 07, 2025
ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.

Francesca Bonechi, Marina Bacci, Nicla Lorito

|Nov 06, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.

Léa Baudre, Gregoire Jouault, Pacôme Prompsy

|Jul 12, 2025
Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells.

Zofia M Komar, Marjolijn M Ladan, Nicole S Verkaik

|Mar 15, 2025
Force transmission is a master regulator of mechanical cell competition.

Andreas Schoenit, Siavash Monfared, Lucas Anger

Pageof 5

Frequent Collaborators

6 joint publications

Laura Sourd

6 joint publications

Rania El-Botty

6 joint publications

Elodie Montaudon

4 joint publications

Violeta Serra